Skip to main content
Raymond Wang, MD, Medical Genetics, Orange, CA

RaymondYu JeangWangMD

Medical Genetics Orange, CA

Clinical Biochemical Genetics, Clinical Genetics

Associate Clinical Professor, Pediatrics, University of California, Irvine College of Medicine

Dr. Wang is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Wang's full profile

Already have an account?

  • Office

    1201 W La Veta Blvd
    Orange, CA 92868
    Phone+1 714-509-8852
    Fax+1 714-509-4531

Summary

  • I am the director of multidisciplinary lysosomal storage disorder program at CHOC Children’s and a board certified clinical geneticist and biochemical genetics specialist.
  • Batten disease pts highlight CHOC as destination hospital for rare diz families

    Rare diseases and rare opportunities

    A story of my journey as a physician scientist, blessed to help children and families with rare diseases seeking treatment.

Education & Training

  • Cedars-Sinai Medical Center
    Cedars-Sinai Medical CenterFellowship, Medical Genetics and Genomics, 2006 - 2007
  • Cedars-Sinai Medical Center
    Cedars-Sinai Medical CenterResidency, Pediatrics, 2001 - 2006
  • David Geffen School of Medicine at UCLA
    David Geffen School of Medicine at UCLAClass of 2001

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2002 - 2026
  • American Board of Medical Genetics and Genomics Clinical Biochemical Genetics
  • American Board of Medical Genetics and Genomics Clinical Genetics and Genomics

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Gene Therapy in Children with MPS I Showing Promise
    Gene Therapy in Children with MPS I Showing PromiseMarch 8th, 2023
  • UCI Earns Designation as CIRM Alpha Clinic with Five-Year, $8 Million Grant
    UCI Earns Designation as CIRM Alpha Clinic with Five-Year, $8 Million GrantOctober 27th, 2022
  • Lysogene Provides Additional Update on AAVance Phase 2/3 Gene Therapy Clinical Trial with LYS-SAF302 in Children with MPS IIIA
    Lysogene Provides Additional Update on AAVance Phase 2/3 Gene Therapy Clinical Trial with LYS-SAF302 in Children with MPS IIIAJuly 7th, 2022
  • Join now to see all

Grant Support

  • Combination Gene Therapy for Treatment of Canine Mucopolysaccharidosis Type IEunice Kennedy Shriver National Institute of Child Health and Human Development2023–2028
  • Alpha Stem Cell ClinicCalifornia Institute of Regenerative Medicine2023–2028
  • Stable therapy in Pompe disease through genome editingNational Institute of Arthritis and Musculoskeletal and Skin Disease2021–2026

Committees

  • Member, CalOptima Pharmacy and Therapeutics Committee 2018 - Present
  • Member, CHOC Clinical Efficacy and Efficiency Committee 2018 - Present

Research History

  • Principal InvestigatorAs PI of the Campbell Foundation of Caring Laboratory, I supervise efforts to develop CRISPR-based gene editing methods for generation of model systems and therapies for inherited lysosomal storage disorders.2017 - Present

Professional Memberships